7,376.86

+23.13

+0.31%

51,285.73

-237.37

-0.46%

24,579.42

+264.42

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

75,670.82

+86.22

+0.11%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

Paris - Delayed Quote EUR

ABIVAX Société Anonyme (ABVX.PA)

77.15 -0.50 (-0.64%)

At close: November 6 at 5:36:06 PM GMT+1

Loading Chart for ABVX.PA

Chart Range Bar

Interval:

In partnership with ChartIQ

Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross?

Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross?

Abivax CEO says $920M raise funds U.S. drug launch without Big Pharma

Abivax CEO says $920M raise funds U.S. drug launch without Big Pharma

Abivax: Wall Street Catches Up to the Data

Abivax: Wall Street Catches Up to the Data

Abivax Announces Closing of $920 Million Public Offering

Abivax Announces Closing of $920 Million Public Offering

Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says

Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says

ABVX Stock Eyes Over Six-Month High As Investors Double Down On Abivax's Lead Drug Bet – Buyout Chatter Builds

ABVX Stock Eyes Over Six-Month High As Investors Double Down On Abivax's Lead Drug Bet – Buyout Chatter Builds

Abivax jumps as fully exercised option lifts share-sale haul to $920 million

Abivax jumps as fully exercised option lifts share-sale haul to $920 million

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

ABIVAX (ENXTPA:ABVX) Stock Looks Expensive Even After Strong Trial Progress

ABIVAX (ENXTPA:ABVX) Stock Looks Expensive Even After Strong Trial Progress

Jefferies upgrades Abivax to Buy, lifts PT as safety concerns over obefazimod ease

Jefferies upgrades Abivax to Buy, lifts PT as safety concerns over obefazimod ease

Abivax Prices $800M Offering Of ADS – Here’s A Look At Some Key Figures

Abivax Prices $800M Offering Of ADS – Here’s A Look At Some Key Figures

Mobilize your Website

View Site in Mobile | Classic

Share by: